Logo

Axxam to Provide Assays for NIH s Molecular Initiative

Jan 09, 2006

NEW YORK, Jan. 9 (GenomeWeb News) - Axxam will provide the National Institutes of Health with assays to be used in screening campaigns within the Molecular Libraries Roadmap Initiative, the company said today.

 

The screening assays were developed and optimized at Axxam for ultra high-throughput screening applications using ultra sensitive signal-detection methods.

 

The selection would be available to the NIH Chemical Genomics Center.

 

Financial details were not disclosed.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.